ALSO NOTED: Merck waits for news on Gardasil, Januvia; Pfizer wins patent case in China; and much more...

> It's a big week for Merck, which is hoping to move two blockbusters--Gardasil and Januvia--past important milestones. Article

> Pfizer won a landmark patent protection case in China, signaling the Chinese government's willingness to protect big drug companies' blockbuster meds. Report (WSJ sub. req.)

> New market research indicates that the growing popularity of Enbrel and Humira will help expand the market for RA drugs to $10 billion in 2015. Release

> Cabrellis Pharmaceuticals announced its launch after its spinout from Conforma Therapeutics, which was sold to Biogen Idec. Report

> WellGen CEO David Evans died after a sudden illness. Release

> Myogen has launched a Phase III trial of Darusentan in patients with resistant hypertension. Release

> The FDA has approved a new wrinkle cream from Allergan. Report

And Finally… Strict mothers were five times more likely to raise overweight children than mothers who were flexible but good at setting rules. Article